Mitogen activated protein kinases in renal fibrosis

Frontiers in Bioscience - Scholar

Volumn 1 S, Issue 1, 2009, Pages 171-187

  Ma, Frank Y ^a   Sachchithananthan, Mythily ^a   Flanc, Robert S ^a   Nikolic Paterson, David J ^a  

^a MONASH UNIVERSITY   (Australia)

Author keywords

ERK; JNK; P38; Renal fibrosis; Review

Indexed keywords

MITOGEN ACTIVATED PROTEIN KINASE;

ANIMAL; ENZYMOLOGY; FIBROSIS; HUMAN; KIDNEY DISEASE; METABOLISM; REVIEW; SIGNAL TRANSDUCTION;

ANIMALS; FIBROSIS; HUMANS; KIDNEY DISEASES; MITOGEN-ACTIVATED PROTEIN KINASES; SIGNAL TRANSDUCTION;

EID: 72949093399     PISSN: 19450516     EISSN: 19450524     Source Type: Journal    
DOI: 10.2741/e17     Document Type: Article

References (157)

1. Coulombe, P. & S. Meloche: Atypica. Mitogen-activated protein kinases: structure, regulation and functions. Biochim Biophys Acta, 1773, 1376-1376 (2007)
2. Kyriakis, J. M. & J. Avruch: Mammalia. Mitogenactivated protein kinase signal transduction pathways activated by stress and inflammation. Physiological reviews, 81, 807-807 (2001)
3. Yasuda, J., A. J. Whitmarsh, J. Cavanagh, M. Sharm. & R. J. Davis: Th. JIP group of mitogen-activated protein kinase scaffold proteins. Mol Cell Biol, 19, 7245-7245 (1999)
4. Raman, M., W. Che. & M. H. Cobb: Differentia. Regulation and properties of MAPKs. Oncogene, 26, 3100-3100 (2007)
5. Owens, D. M. & S. M. Keyse: Differentia. Regulation of MAP kinase signalling by dual-specificity protein phosphatases. Oncogene, 26, 3203-3203 (2007)
6. Gerits, N., S. Kostenk. & U. Moens: I. Vivo functions of mitogen-activated protein kinases: conclusions from knockin and knock-out mice. Transgenic Research, 16, 281-281 (2007)
7. Omori, S., M. Hida, K. Ishikura, S. Kuramoch. & M. Awazu: Expressio. Of mitogen-activated protein kinase family in rat renal development. Kidney Int, 58, 27-27 (2000)
8. Hida, M., S. Omor. & M. Awazu: ER. And p38 MAP kinase are required for rat renal development. Kidney Int, 61, 1252-1252 (2002)
9. Bokemeyer, D., K. E. Guglielmi, A. McGinty, A. Sorokin, E. A. Lianos & M. J. Dunn: Activatio. Of extracellular signalregulated kinase in proliferative glomerulonephritis in rats. J Clin Invest, 100, 582-582 (1997)
10. Masaki, T., C. Stambe, P. A. Hill, J. Dowling, R. C. Atkin. & D. J. Nikolic-Paterson: Activatio. Of the extracellular-signal regulated protein kinase pathway in human glomerulopathies. J Am Soc Nephrol, 15, 1835-1835 (2004)
11. Masaki, T., R. Foti, P. A. Hill, Y. Ikezumi, R. C. Atkin. & D. J. Nikolic-Paterson: Activatio. Of the ERK pathway precedes tubular proliferation in the obstructed rat kidney. Kidney Int, 63, 1256-1256 (2003)
12. Cheng, H. F., J. L. Wang, M. Z. Zhang, J. A. McKann. & R. C. Harris: Rol. Of p38 in the regulation of renal cortical cyclooxygenase-2 expression by extracellular chloride. J Clin Invest, 106, 681-681 (2000)
13. Wada, T., K. Furuichi, N. Sakai, Y. Hisada, K. Kobayashi, N. Mukaida, N. Tomosugi, K. Matsushima & H. Yokoyama: Involvemen. Of p38 mitogen-activated protein kinase followed by chemokine expression in crescentic glomerulonephritis. Am J Kidney Dis, 38, 1169-1169 (2001)
14. Stambe, C., D. J. Nikolic-Paterson, P. A. Hill, J. Dowlin. & R. C. Atkins: p3. Mitogen-activated protein kinase activation and cell localization in human glomerulonephritis: correlation with renal injury. J Am Soc Nephrol, 15, 326-326 (2004)
15. Adhikary, L., F. Chow, D. J. Nikolic-Paterson, C. Stambe, J. Dowling, R. C. Atkins & G. H. Tesch: Abnorma. P38 mitogen-activated protein kinase signalling in human and experimental diabetic nephropathy. Diabetologia, 47, 1210-1210 (2004)
16. Ma, F. Y., R. S. Flanc, G. H. Tesch, Y. Han, R. C. Atkins, B. L. Bennett, G. C. Friedman, J. H. Fan & D. J. Nikolic-Paterson: A pathogeni. Role for c-Jun. Aminoterminal kinase signaling in renal fibrosis and tubular cell apoptosis. J Am Soc Nephrol, 18, 472-472 (2007)
17. Maruyama, M., Y. Yagasaki, T. Sud. & H. Osada: Rena. Abnormalities in mice caused by insufficiency of p38alpha. J Recep Signal Transduction Res, 23, 173-173 (2003)
18. Bustamante, M., F. Roger, M. L. Bochaton-Piallat, G. Gabbiani, P. Y. Martin & E. Feraille: Regulator. Volume increase is associated with p38 kinasedependent actin cytoskeleton remodeling in rat kidney MTAL. Am J Physiol Renal Physiol, 285, F336-347 (2003) (Pubitemid 36871207)
19. Taruno, A., N. Niisat. & Y. Marunaka: Hypotonicit. Stimulates renal epithelial sodium transport by activating JNK via receptor tyrosine kinases. Am J Physiol Renal Physiol, 293, F128-138 (2007) (Pubitemid 47345011)
20. Capasso, J. M., C. J. Rivar. & T. Berl: Synthesi. Of the Na-K-ATPase gamma-subunit is regulated at both the transcriptional and translational levels in IMCD3 cells. Am J Physiol Renal Physiol, 288, F76-81 (2005) (Pubitemid 40038678)
21. Ohashi, R., T. Nakagawa, S. Watanabe, J. Kanellis, R. G. Almirez, G. F. Schreiner & R. J. Johnson: Inhibitio. Of p38 mitogen-activated protein kinase augments progression of remnant kidney model by activating the ERK pathway. Am J Pathol, 164, 477-477 (2004)
22. Bottinger, E. P.: TGF-bet. In renal injury and disease. Semin Nephrol, 27, 309-309 (2007)
23. Lawrence, D. A.: Latent-TGF-beta. An overview. Mol Cell Biochem, 219, 163-163 (2001)
24. Wang, W., V. Kok. & H. Y. Lan: Transformin. Growth factor-beta and Smad signalling in kidney diseases. Nephrology (Carlton), 10, 48-48 (2005)
25. Kim, S. J., P. Angel, R. Lafyatis, K. Hattori, K. Y. Kim, M. B. Sporn, M. Karin & A. B. Roberts: Autoinductio. Of transforming growth factor beta 1 is mediated by the AP-1 complex. Mol Cell Biol, 10, 1492-1492 (1990)
26. Kim, S. J., F. Denhez, K. Y. Kim, J. T. Holt, M. B. Spor. & A. B. Roberts: Activatio. Of the second promoter of the transforming growth factor-beta 1 gene by transforming growth factor-beta 1 and phorbol ester occurs through the same target sequences. J Biol Chem, 264, 19373-19373 (1989)
27. Zenz, R. & E. F. Wagner: Ju. Signalling in the epidermis: From developmental defects to psoriasis and skin tumors. Int J Biochem Cell Biol, 38, 1043-1043 (2006)
28. Kagami, S., W. A. Border, D. E. Mille. & N. A. Noble: Angiotensi. II stimulates extracellular matrix protein synthesis through induction of transforming growth factor-beta expression in rat glomerular mesangial cells. J Clin Invest, 93, 2431-2431 (1994)
29. Naito, T., T. Masaki, D. J. Nikolic-Paterson, C. Tanji, N. Yoriok. & N. Kohno: Angiotensi. II induces thrombospondin-1 production in human mesangial cells via p38 MAPK and JNK: a mechanism for activation of latent TGF-beta1. Am J Physiol Renal Physiol, 286, F278-287 (2004) (Pubitemid 38141671)
30. Perlman, A., L. M. Lawsin, P. Kolachana, M. Saji, J. Moore, Jr. & M. D. Ringel: Angiotensi. II regulation of TGF-beta in murine mesangial cells involves both PI3 kinase and MAP kinase. Ann Clin Lab Sci, 34, 277-277 (2004)
31. Isono, M., M. C. Cruz, S. Chen, S. W. Hon. & F. N. Ziyadeh: Extracellula. Signal-regulated kinase mediates stimulation of TGF-beta1 and matrix by high glucose in mesangial cells. J Am Soc Nephrol, 11, 2222-2222 (2000)
32. Weigert C, S. U., Brodbeck K, Pfeiffer A, Häring HU, Schleicher ED.: AP-. Proteins mediate hyperglycemia-induced activation of the human TGF-beta1 promoter in mesangial cells. J Am Soc Nephrol, 11, 2007-2007 (2000)
33. Lee, K. Y., K. Ito, R. Hayashi, E. P. Jazrawi, P. J. Barne. & I. M. Adcock: NF-kappa. And activator protein 1 response elements and the role of histone modifications in IL-1beta-induced TGF-beta1 gene transcription. J Immunol, 176, 603-603 (2006)
34. Sullivan, D. E., M. Ferris, D. Pocias. & A. R. Brody: Tumo. Necrosis factor-alpha induces transforming growth factor-beta1 expression in lung fibroblasts through the extracellular signal-regulated kinase pathway. Am J Respir Cell Mol Biol, 32, 342-342 (2005)
35. Zhang, M., D. Frase. & A. Phillips: ERK. P38, and Smad signaling pathways differentially regulate transforming growth factor-beta1 autoinduction in proximal tubular epithelial cells. Am J Pathol, 169, 1282-1282 (2006)
36. Engel ME, M. M., Law BK, Moses HL.: Interdependen. SMAD and JNK signaling in transforming growth factor-beta-mediated transcription. J Biol Chem, 274, 37413-37413 (1999)
37. Yu, L., M. C. Heber. & Y. E. Zhang: TGF-bet. Receptor-activated p38 MAP kinase mediates Smadindependent TGF-beta responses. EMBO J, 21, 3749-3749 (2002)
38. Derynck, R. & Y. E. Zhang: Smad-dependen. And Smad-independent pathways in TGF-beta family signalling. Nature, 425, 577-577 (2003)
39. Lee, M. K., C. Pardoux, M. C. Hall, P. S. Lee, D. Warburton, J. Qing, S. M. Smith & R. Derynck: TGF-bet. Activates Erk MAP kinase signalling through direct phosphorylation of ShcA. EMBO J, 26, 3957-3957 (2007)
40. Yamaguchi, K., K. Shirakabe, H. Shibuya, K. Irie, I. Oishi, N. Ueno, T. Taniguchi, E. Nishida & K. Matsumoto: Identificatio. Of a member of the MAPKKK family as a potential mediator of TGF-beta signal transduction. Science, 270, 2008-2008 (1995)
41. Wang, C., L. Deng, M. Hong, G. R. Akkaraju, J. Inou. & Z. J. Chen: TAK. Is a ubiquitin-dependent kinase of MKK and IKK. Nature, 412, 346-346 (2001)
42. Shibuya, H., K. Yamaguchi, K. Shirakabe, A. Tonegawa, Y. Gotoh, N. Ueno, K. Irie, E. Nishida & K. Matsumoto: TAB1. An activator of the TAK1 MAPKKK in TGF-beta signal transduction. Science, 272, 1179-1179 (1996)
43. Holtmann, H., J. Enninga, S. Kalble, A. Thiefes, A. Dorrie, M. Broemer, R. Winzen, A. Wilhelm, J. Ninomiya-Tsuji, K. Matsumoto, K. Resch & M. Kracht: Th. MAPK kinase kinase TAK1 plays a central role in coupling the interleukin-1 receptor to both transcriptional and RNA-targeted mechanisms of gene regulation. J Biol Chem, 276, 3508-3508 (2001)
44. Funaba, M., C. M. Zimmerma. & L. S. Mathews: Modulatio. Of Smad2-mediated signaling by extracellular signal-regulated kinase. J Biol Chem, 277, 41361-41361 (2002)
45. Hayashida, T., M. Decaestecke. & H. W. Schnaper: Cross-tal. Between ERK MAP kinase and Smad signaling pathways enhances TGF-beta-dependent responses in human mesangial cells. Faseb J, 17, 1576-1576 (2003)
46. Furukawa, F., K. Matsuzaki, S. Mori, Y. Tahashi, K. Yoshida, Y. Sugano, H. Yamagata, M. Matsushita, T. Seki, Y. Inagaki, M. Nishizawa, J. Fujisawa & K. Inoue: p3. MAPK mediates fibrogenic signal through Smad3 phosphorylation in rat myofibroblasts. Hepatology, 38, 879-879 (2003)
47. Mori, S., K. Matsuzaki, K. Yoshida, F. Furukawa, Y. Tahashi, H. Yamagata, G. Sekimoto, T. Seki, H. Matsui, M. Nishizawa, J. Fujisawa & K. Okazaki: TGF-bet. And HGF transmit the signals through JNK-dependent Smad2/3 phosphorylation at the linker regions. Oncogene, 23, 7416-7416 (2004)
48. Yoshida, K., K. Matsuzaki, S. Mori, Y. Tahashi, H. Yamagata, F. Furukawa, T. Seki, M. Nishizawa, J. Fujisawa & K. Okazaki: Transformin. Growth factorbeta and platelet-derived growth factor signal via c-Jun. N-terminal kinase-dependent Smad2/3 phosphorylation in rat hepatic stellate cells after acute liver injury. Am J Pathol, 166, 1029-1029 (2005)
49. Verrecchia, F., M. Pessah, A. Atf. & A. Mauviel: Tumo. Necrosis factor-alpha inhibits transforming growth factor-beta/Smad signaling in human dermal fibroblasts via AP-1 activation. J Biol Chem, 275, 30226-30226 (2000)
50. Verrecchia, F., C. Tacheau, E. F. Wagne. & A. Mauviel: A centra. Role for the JNK pathway in mediating the antagonistic activity of pro-inflammatory cytokines against transforming growth factor-betadriven SMAD3/4-specific gene expression. J Biol Chem, 278, 1585-1585 (2003)
51. Li, J. H., X. R. Huang, H. J. Zhu, M. Oldfield, M. Cooper, L. D. Truong, R. J. Johnson & H. Y. Lan: Advance. Glycation end products activate Smad signaling via TGF-beta-dependent and independent mechanisms: implications for diabetic renal and vascular disease. Faseb J, 18, 176-176 (2004)
52. Rodriguez-Vita, J., E. Sanchez-Lopez, V. Esteban, M. Ruperez, J. Egido & M. Ruiz-Ortega: Angiotensi. II activates the Smad pathway in vascular smooth muscle cells by a transforming growth factor-beta-independent mechanism. Circulation, 111, 2509-2509 (2005)
53. Uchida K, S. H., Ohashi T, Nitta K, Yumura W, Nihei H.: Involvemen. Of MAP kinase cascades in Smad7 transcriptional regulation. Biochem Biophys Res Commun, 289, 376-376 (2001)
54. Ohshima, T. & K. Shimotohno: Transformin. Growth factor-beta-mediated signaling via the p38 MAP kinase pathway activates Smad-dependent transcription through SUMO-1 modification of Smad4. J Biol Chem, 278, 50833-50833 (2003)
55. Desmouliere, A., C. Chaponnie. & G. Gabbiani: Tissu. Repair, contraction, and the myofibroblast. Wound Repair Regen, 13, 7-7 (2005)
56. Wada, T., N. Sakai, K. Matsushim. & S. Kaneko: Fibrocytes. A new insight into kidney fibrosis. Kidney Int, 72, 269-269 (2007)
57. Liu, Y.: Epithelia. To mesenchymal transition in renal fibrogenesis: pathologic significance, molecular mechanism, and therapeutic intervention. J Am Soc Nephrol, 15, 1-1 (2004)
58. Shimizu, F., H. Kawach. & M. Orikasa: Rol. Of mesangial cell damage in progressive renal disease. Kidney Blood Pressure Res, 22, 5-5 (1999)
59. Gomez-Guerrero, C., P. Hernandez-Vargas, O. Lopez-Franco, G. Ortiz-Munoz & J. Egido: Mesangia. Cells and glomerular inflammation: from the pathogenesis to novel therapeutic approaches. Current Drug Targets, 4, 341-341 (2005)
60. Schlaepfer, D. D., S. K. Mitr. & D. Ilic: Contro. Of motile and invasive cell phenotypes by focal adhesion kinase. Biochim Biophys Acta, 1692, 77-77 (2004)
61. Tangkijvanich, P., C. Santiskulvong, A. C. Melton, E. Rozengur. & H. F. Yee, Jr.: p3. MAP kinase mediates platelet-derived growth factor-stimulated migration of hepatic myofibroblasts. J Cell Physiol, 191, 351-351 (2002)
62. Javelaud, D., J. Laboureau, E. Gabison, F. Verrecchi. & A. Mauviel: Disruptio. Of basal JNK activity differentially affects key fibroblast functions important for wound healing. J Biol Chem, 278, 24624-24624 (2003)
63. Yujiri, T., M. Ware, C. Widmann, R. Oyer, D. Russell, E. Chan, Y. Zaitsu, P. Clarke, K. Tyler, Y. Oka, G. R. Fanger, P. Henson & G. L. Johnson: ME. Kinase 1 gene disruption alters cell migration and c-Jun. NH2-terminal kinase regulation but does not cause a measurable defect in NF-kappa B activation. Proc Natl Acad Sci U S A, 97, 7272-7272 (2000)
64. Kennedy, L., S. Liu, X. Shi-Wen, Y. Chen, M. Eastwood, D. E. Carter, K. M. Lyons, C. M. Black, D. J. Abraham & A. Leask: CCN. Is necessary for the function of mouse embryonic fibroblasts. Exp Cell Res, 313, 952-952 (2007)
65. Ng Y-Y, N.-P. D., Mu W, Atkins RC, Lan HY: Expressio. Of basic fibroblast growth factor and its receptor in the progression of rat crescentic glomerulonephritis. Nephrology, 1, 569-569 (1995)
66. Yang, N., L. L. Wu, D. J. Nikolic-Paterson, Y. Y. Ng, W. C. Yang, W. Mu, R. E. Gilbert, M. E. Cooper, R. C. Atkins & H. Y. Lan: Loca. Macrophage and myofibroblast proliferation in progressive renal injury in the rat remnant kidney. Nephrol Dial Transplant, 13, 1967-1967 (1998)
67. Mandal, S. K., L. V. Rao, T. T. Tra. & U. R. Pendurthi: A nove. Mechanism of plasmin-induced mitogenesis in fibroblasts. J Thromb Haemost, 3, 163-163 (2005)
68. Grotendorst, G. R., H. Rahmani. & M. R. Duncan: Combinatoria. Signaling pathways determine fibroblast proliferation and myofibroblast differentiation. Faseb J, 18, 469-469 (2004)
69. Reeves, H. L., C. L. Dack, M. Peak, A. D. Bur. & C. P. Day: Stress-activate. Protein kinases in the activation of rat hepatic stellate cells in culture. J Hepatol, 32, 465-465 (2000)
70. Hu, Y., J. Peng, D. Feng, L. Chu, X. Li, Z. Jin, Z. Li. & Q. Zeng: Rol. Of extracellular signal-regulated kinase, p38 kinase, and activator protein-1 in transforming growth factor-beta1-induced alpha smooth muscle actin expression in human fetal lung fibroblasts in vitro. Lung, 184, 33-33 (2006)
71. Smith, P. C., M. Cacere. & J. Martinez: Inductio. Of the myofibroblastic phenotype in human gingival fibroblasts by transforming growth factor-beta1: role of RhoA-ROCK and c-Jun. N-terminal kinase signaling pathways. J Periodon Res, 41, 418-418 (2006)
72. Sousa, A. M., T. Liu, O. Guevara, J. Stevens, B. L. Fanburg, M. Gaestel, D. Toksoz & U. S. Kayyali: Smoot. Muscle alpha-actin expression and myofibroblast differentiation by TGFbeta are dependent upon MK2. J Cell Biochem, 100, 1581-1581 (2007)
73. Liu, T., R. R. Warburton, O. E. Guevara, N. S. Hill, B. L. Fanburg, M. Gaestel & U. S. Kayyali: Lac. Of MK2 Inhibits Myofibroblast Formation and Exacerbates Pulmonary Fibrosis. Am J Respir Cell Mol Biol, 37, 507-507 (2007)
74. Strutz, F., H. Okada, C. W. Lo, T. Danoff, R. L. Carone, J. E. Tomaszewski & E. G. Neilson: Identificatio. And characterization of a fibroblast marker: FSP1. J Cell Biol, 130, 393-393 (1995)
75. Jinde, K., D. J. Nikolic-Paterson, X. R. Huang, H. Sakai, K. Kurokawa, R. C. Atkins & H. Y. Lan: Tubula. Phenotypic change in progressive tubulointerstitial fibrosis in human glomerulonephritis. Am J Kidney Dis, 38, 761-761 (2001)
76. Ng, Y. Y., T. P. Huang, W. C. Yang, Z. P. Chen, A. H. Yang, W. Mu, D. J. Nikolic-Paterson, R. C. Atkins & H. Y. Lan: Tubula. Epithelial-myofibroblast transdifferentiation in progressive tubulointerstitial fibrosis in 5/6 nephrectomized rats. Kidney Int, 54, 864-864 (1998)
77. Oldfield, M. D., L. A. Bach, J. M. Forbes, D. Nikolic-Paterson, A. McRobert, V. Thallas, R. C. Atkins, T. Osicka, G. Jerums & M. E. Cooper: Advance. Glycation end products cause epithelialmyofibroblast transdifferentiation via the receptor for advanced glycation end products (RAGE). J Clin Invest, 108, 1853-1853 (2001)
78. Iwano, M., D. Plieth, T. M. Danoff, C. Xue, H. Okad. & E. G. Neilson: Evidenc. That fibroblasts derive from epithelium during tissue fibrosis. J Clin Invest, 110, 341-341 (2002)
79. Ng, Y. Y., J. M. Fan, W. Mu, D. J. Nikolic-Paterson, W. C. Yang, T. P. Huang, R. C. Atkins & H. Y. Lan: Glomerula. Epithelial-myofibroblast transdifferentiation in the evolution of glomerular crescent formation. Nephrol Dial Transplant, 14, 2860-2860 (1999)
80. Bariety, J., G. S. Hill, C. Mandet, T. Irinopoulou, C. Jacquot, A. Meyrier & P. Bruneval: Glomerula. Epithelial-mesenchymal transdifferentiation in pauciimmune crescentic glomerulonephritis. Nephrol Dial Transplant, 18, 1777-1777 (2003)
81. Fan, J. M., Y. Y. Ng, P. A. Hill, D. J. Nikolic-Paterson, W. Mu, R. C. Atkins & H. Y. Lan: Transformin. Growth factor-beta regulates tubular epithelial-myofibroblast transdifferentiation in vitro. Kidney Int, 56, 1455-1455 (1999)
82. Fan, J. M., X. R. Huang, Y. Y. Ng, D. J. Nikolic-Paterson, W. Mu, R. C. Atkins & H. Y. Lan: Interleukin-. Induces tubular epithelial-myofibroblast transdifferentiation through a transforming growth factor-beta1-dependent mechanism in vitro. Am J Kidney Dis, 37, 820-820 (2001)
83. Burns, W. C., S. M. Twigg, J. M. Forbes, J. Pete, C. Tikellis, V. Thallas-Bonke, M. C. Thomas, M. E. Cooper & P. Kantharidis: Connectiv. Tissue growth factor plays an important role in advanced glycation end product-induced tubular epithelial-to-mesenchymal transition: implications for diabetic renal disease. J Am Soc Nephrol, 17, 2484-2484 (2006)
84. Rhyu, D. Y., Y. Yang, H. Ha, G. T. Lee, J. S. Song, S. T. U. & H. B. Lee: Rol. Of reactive oxygen species in TGF-beta1-induced mitogen-activated protein kinase activation and epithelial-mesenchymal transition in renal tubular epithelial cells. J Am Soc Nephrol, 16, 667-667 (2005)
85. Xie, L., B. K. Law, A. M. Chytil, K. A. Brown, M. E. Aakr. & H. L. Moses: Activatio. Of the Erk pathway is required for TGF-beta1-induced EMT in vitro. Neoplasia, 6, 603-603 (2004)
86. Li, M., K. S. Hering-Smith, E. E. Simo. & V. Batuman: Myelom. Light chains induce epithelial mesenchymal transition in human renal proximal tubule epithelial cells. Nephrol Dial Transplant, 23, 860-860 (2007)
87. Li, J. H., W. Wang, X. R. Huang, M. Oldfield, A. M. Schmidt, M. E. Cooper & H. Y. Lan: Advance. Glycation end products induce tubular epithelial-myofibroblast transition through the RAGE-ERK1/2 MAP kinase signaling pathway. Am J Pathol, 164, 1389-1389 (2004)
88. Pollack, V., R. Sarkozi, Z. Banki, E. Feifel, S. Wehn, G. Gstraunthaler, H. Stoiber, G. Mayer, R. Montesano, F. Strutz & H. Schramek: Oncostati. M-induced effects on EMT in human proximal tubular cells: differential role of ERK signaling. Am J Physiol Renal Physiol, 293, F1714-1726 (2007) (Pubitemid 350086008)
89. Zavadil, J., M. Bitzer, D. Liang, Y. C. Yang, A. Massimi, S. Kneitz, E. Piek & E. P. Bottinger: Geneti. Programs of epithelial cell plasticity directed by transforming growth factor-beta. Proc Natl Acad Sci U S A, 98, 6686-6686 (2001)
90. Bakin, A. V., C. Rinehart, A. K. Tomlinso. & C. L. Arteaga: p3. Mitogen-activated protein kinase is required for TGFbeta-mediated fibroblastic transdifferentiation and cell migration. J Cell Science, 115, 3193-3193 (2002)
91. Santibanez, J. F.: JN. Mediates TGF-beta1-induced epithelial mesenchymal transdifferentiation of mouse transformed keratinocytes. FEBS Letters, 580, 5385-5385 (2006)
92. Armendariz-Borunda, J., C. P. Simkevich, N. Roy, R. Raghow, A. H. Kang & J. M. Seyer: Activatio. Of Ito cells involves regulation of AP-1 binding proteins and induction of type I collagen gene expression. Biochem J, 304, 817-817 (1994)
93. Chung, K. Y., A. Agarwal, J. Uitt. & A. Mauviel: A. AP-1 binding sequence is essential for regulation of the human alpha2 (I) collagen (COL1A2) promoter activity by transforming growth factor-beta. J Biol Chem, P-1 binding sequence is essential for regulation of the human alpha2 (I) collagen (COL1A2) promoter activity by transforming growth factor-beta. J Biol Chem, 271, 3272-3272 (1996)
94. Moriguchi, Y., H. Matsubara, Y. Mori, S. Murasawa, H. Masaki, K. Maruyama, Y. Tsutsumi, Y. Shibasaki, Y. Tanaka, T. Nakajima, K. Oda & T. Iwasaka: Angiotensi. II-induced transactivation of epidermal growth factor receptor regulates fibronectin and transforming growth factor-beta synthesis via transcriptional and posttranscriptional mechanisms. Circ Res, I-induced transactivation of epidermal growth factor receptor regulates fibronectin and transforming growth factor-beta synthesis via transcriptional and posttranscriptional mechanisms. Circ Res, 84, 1073-1073 (1999)
95. Gruden, G., S. Zonca, A. Hayward, S. Thomas, S. Maestrini, L. Gnud. & G. C. Viberti: Mechanica. Stretchinduced fibronectin and transforming growth factor-beta1 production in human mesangial cells is p38 mitogen-activated protein kinase-dependent. Diabetes, 49, 655-655 (2000)
96. Uchiyama-Tanaka, Y., H. Matsubara, Y. Nozawa, S. Murasawa, Y. Mori, A. Kosaki, K. Maruyama, H. Masaki, Y. Shibasaki, S. Fujiyama, A. Nose, O. Iba, T. Hasagawa, E. Tateishi, S. Higashiyama & T. Iwasaka: Angiotensi. II signaling and HB-EGF shedding via metalloproteinase in glomerular mesangial cells. Kidney Int, 60, 2153-2153 (2001)
97. Inoki, K., M. Haneda, T. Ishida, H. Mori, S. Maeda, D. Koya, T. Sugimoto & R. Kikkawa: Rol. Of mitogenactivated protein kinases as downstream effectors of transforming growth factor-beta in mesangial cells. Kidney Int, Suppl 77, S76-80 (2000)
98. Chin, B. Y., A. Mohsenin, S. X. Li, A. M. Cho. & M. E. Choi: Stimulatio. Of pro-alpha (1) (I) collagen by TGF-beta (1) in mesangial cells: role of the p38 MAPK pathway. Am J Physiol Renal Physiol, 280, F495-504 (2001)
99. Hayashida, T., A. C. Poncelet, S. C. Hubcha. & H. W. Schnaper: TGF-beta. Activates MAP kinase in human mesangial cells: a possible role in collagen expression. Kidney Int, 56, 1710-1710 (1999)
100. Suzuki, H., K. Uchida, K. Nitt. & H. Nihei: Rol. Of mitogen-activated protein kinase in the regulation of transforming growth factor-beta-induced fibronectin accumulation in cultured renal interstitial fibroblasts. Clin Exp Nephrol, 8, 188-188 (2004)
101. De Borst, M., J. Prakash, W. Melenhorst, M. Van den Heuvel, R. Kok, G. Navis & H. Van Goor: Glomerula. And tubular induction of the transcription factor c-Jun. In human renal disease. J Pathol, 213, 219-219 (2007)
102. Wang, X. M., Y. Zhang, H. P. Kim, Z. Zhou, C. A. Feghali-Bostwick, F. Liu, E. Ifedigbo, X. Xu, T. D. Oury, N. Kaminski & A. M. Choi: Caveolin-1. A critical regulator of lung fibrosis in idiopathic pulmonary fibrosis. J Exp Med, 203, 2895-2895 (2006)
103. Gupta, S., M. R. Clarkson, J. Dugga. & H. R. Brady: Connectiv. Tissue growth factor: potential role in glomerulosclerosis and tubulointerstitial fibrosis. Kidney Int, 58, 1389-1389 (2000)
104. Phanish, M. K., N. A. Wahab, B. M. Hendr. & M. E. Dockrell: TGF-beta1-induce. Connective tissue growth factor (CCN2) expression in human renal proximal tubule epithelial cells requires Ras/MEK/ERK and Smad signalling. Nephron Exp Nephrol, 100, e156-165 (2005) (Pubitemid 40910994)
105. Utsugi, M., K. Dobashi, T. Ishizuka, K. Masubuchi, Y. Shimizu, T. Nakazawa & M. Mori: C-Jun-NH2. Terminal kinase mediates expression of connective tissue growth factor induced by transforming growth factorbeta1 in human lung fibroblasts. Am J Respir Cell Mol Biol, 28, 754-754 (2003)
106. Leask, A., A. Holmes, C. M. Blac. & D. J. Abraham: Connectiv. Tissue growth factor gene regulation. Requirements for its induction by transforming growth factor-beta 2 in fibroblasts. J Biol Chem, 278, 13008-13008 (2003)
107. Ishida, T., M. Haneda, S. Maeda, D. Koy. & R. Kikkawa: Stretch-induce. Overproduction of fibronectin in mesangial cells is mediated by the activation of mitogen-activated protein kinase. Diabetes, 48, 595-595 (1999)
108. Cohen, M. P., E. She. & C. W. Shearman: ER. Mediates effects of glycated albumin in mesangial cells. Biochem Biophys Res Commun, 283, 641-641 (2001)
109. Sekine, S., K. Nitta, K. Uchida, W. Yumur. & H. Nihei: Possibl. Involvement of mitogen-activated protein kinase in the angiotensin II-induced fibronectin synthesis in renal interstitial fibroblasts. Arch Biochem Biophys, 415, 63-63 (2003)
110. Catania, J. M., G. Che. & A. R. Parrish: Rol. Of matrix metalloproteinases in renal pathophysiologies. Am J Physiol Renal Physiol, 292, F905-911 (2007) (Pubitemid 46393417)
111. Guo, B., K. Inoki, M. Isono, H. Mori, K. Kanasaki, T. Sugimoto, S. Akiba, T. Sato, B. Yang, R. Kikkawa, A. Kashiwagi, M. Haneda & D. Koya: MAPK/AP-1. Dependent regulation of PAI-1 gene expression by TGF-beta in rat mesangial cells. Kidney Int, 68, 972-972 (2005)
112. Yang, C., K. Patel, P. Harding, A. Soroki. & W. F. Glass, 2nd: Regulatio. Of TGF-beta1/MAPK-mediated PAI-1 gene expression by the actin cytoskeleton in human mesangial cells. Exp Cell Res, 313, 1240-1240 (2007)
113. Kietzmann, T., K. Jungerman. & A. Gorlach: Regulatio. Of the hypoxia-dependent plasminogen activator inhibitor 1 expression by MAP kinases. Thromb Haemost, 89, 666-666 (2003)
114. Oda, T., Y. O. Jung, H. S. Kim, X. Cai, J. M. Lopez-Guisa, Y. Ikeda & A. A. Eddy: PAI-. Deficiency attenuates the fibrogenic response to ureteral obstruction. Kidney Int, 60, 587-587 (2001)
115. Nicholas, S. B., E. Aguiniga, Y. Ren, J. Kim, J. Wong, N. Govindarajan, M. Noda, W. Wang, Y. Kawano, A. Collins & W. A. Hsueh: Plasminoge. Activator inhibitor-1 deficiency retards diabetic nephropathy. Kidney Int, 67, 1297-1297 (2005)
116. Zhang, G., K. A. Kernan, S. J. Collins, X. Cai, J. M. Lopez-Guisa, J. L. Degen, Y. Shvil & A. A. Eddy: Plasmi. (ogen) promotes renal interstitial fibrosis by promoting epithelial-to-mesenchymal transition: role of plasmin-activated signals. J Am Soc Nephrol, 18, 846-846 (2007)
117. Kim, H., T. Oda, J. Lopez-Guisa, D. Wing, D. R. Edwards, P. D. Soloway & A. A. Eddy: TIMP-. Deficiency does not attenuate interstitial fibrosis in obstructive nephropathy. J Am Soc Nephrol, 12, 736-736 (2001)
118. Ravanti, L., L. Hakkinen, H. Larjava, U. Saarialho-Kere, M. Foschi, J. Han & V. M. Kahari: Transformin. Growth factor-beta induces collagenase-3 expression by human gingival fibroblasts via p38 mitogen-activated protein kinase. J Biol Chem, 274, 37292-37292 (1999)
119. Eberhardt, W., A. Huwiler, K. F. Beck, S. Walpe. & J. Pfeilschifter: Amplificatio. Of IL-1 beta-induced matrix metalloproteinase-9 expression by superoxide in rat glomerular mesangial cells is mediated by increased activities of NF-kappa B and activating protein-1 and involves activation of the mitogen-activated protein kinase pathways. J Immunol, 165, 5788-5788 (2000)
120. Hammaker, D. R., D. L. Boyle, T. Inou. & G. S. Firestein: Regulatio. Of the JNK pathway by TGF-beta activated kinase 1 in rheumatoid arthritis synoviocytes. Arthritis Res Ther, 9, R57 (2007)
121. Yu, X., S. G. Lin, X. R. Huang, M. Bacher, L. Leng, R. Bucal. & H. Y. Lan: Macrophag. Migration inhibitory factor induces MMP-9 expression in macrophages via the MEK-ERK MAP kinase pathway. J Interferon Cytokine Res, 27, 103-103 (2007)
122. Lelongt, B., S. Bengatta, M. Delauche, L. R. Lund, Z. Wer. & P. M. Ronco: Matri. Metalloproteinase 9 protects mice from anti-glomerular basement membrane nephritis through its fibrinolytic activity. J Exp Med, 193, 793-793 (2001)
123. Cheng, S., A. S. Pollock, R. Mahimkar, J. L. Olso. & D. H. Lovett: Matri. Metalloproteinase 2 and basement membrane integrity: a unifying mechanism for progressive renal injury. Faseb J, 20, 1898-1898 (2006)
124. Kim, E. S., M. S. Ki. & A. Moon: TGF-beta-induce. Upregulation of MMP-2 and MMP-9 depends on p38 MAPK, but not ERK signaling in MCF10A human breast epithelial cells. Int J Oncol, 25, 1375-1375 (2004)
125. Stambe, C., R. C. Atkins, G. H. Tesch, A. M. Kapoun, P. A. Hill, G. F. Schreiner & D. J. Nikolic-Paterson: Blockad. Of p38alpha MAPK ameliorates acute inflammatory renal injury in rat anti-GBM glomerulonephritis. J Am Soc Nephrol, 14, 338-338 (2003)
126. Koshikawa, M., M. Mukoyama, K. Mori, T. Suganami, K. Sawai, T. Yoshioka, T. Nagae, H. Yokoi, H. Kawachi, F. Shimizu, A. Sugawara & K. Nakao: Rol. Of p38 mitogen-activated protein kinase activation in podocyte injury and proteinuria in experimental Nephrotic syndrome. J Am Soc Nephrol, 16, 2690-2690 (2005)
127. Sheryanna, A., G. Bhangal, J. McDaid, J. Smith, A. Manning, B. M. Foxwell, M. Feldmann, H. T. Cook, C. D. Pusey & F. W. Tam: Inhibitio. Of p38 mitogen-activated protein kinase is effective in the treatment of experimental crescentic glomerulonephritis and suppresses monocyte chemoattractant protein-1 but not IL-1beta or IL-6. J Am Soc Nephrol, 18, 1167-1167 (2007)
128. Klahr, S. & J. Morrissey: Obstructiv. Nephropathy and renal fibrosis. Am J Physiol Renal Physiol, 283, F861-875 (2002)
129. Ishidoya, S., J. Morrissey, R. McCracken, A. Reye. & S. Klahr: Angiotensi. II receptor antagonist ameliorates renal tubulointerstitial fibrosis caused by unilateral ureteral obstruction. Kidney Int, 47, 1285-1285 (1995)
130. Miyajima, A., J. Chen, C. Lawrence, S. Ledbetter, R. A. Soslow, J. Stern, S. Jha, J. Pigato, M. L. Lemer, D. P. Poppas, E. D. Vaughan & D. Felsen: Antibod. To transforming growth factor-beta ameliorates tubular apoptosis in unilateral ureteral obstruction. Kidney Int, 58, 2301-2301 (2000)
131. Yokoi, H., M. Mukoyama, T. Nagae, K. Mori, T. Suganami, K. Sawai, T. Yoshioka, M. Koshikawa, T. Nishida, M. Takigawa, A. Sugawara & K. Nakao: Reductio. In connective tissue growth factor by antisense treatment ameliorates renal tubulointerstitial fibrosis. J Am Soc Nephrol, 15, 1430-1430 (2004)
132. Shappell, S. B., T. Gurpinar, J. Lechago, W. N. Suk. & L. D. Truong: Chroni. Obstructive uropathy in severe combined immunodeficient (SCID) mice: lymphocyte infiltration is not required for progressive tubulointerstitial injury. J Am Soc Nephrol, 9, 1008-1008 (1998)
133. Nishida, M., Y. Okumura, S. Fujimoto, I. Shiraishi, T. Ito. & K. Hamaoka: Adoptiv. Transfer of macrophages ameliorates renal fibrosis in mice. Biochem Biophys Res Commun, 332, 11-11 (2005)
134. Sung, S. A., S. K. Jo, W. Y. Cho, N. H. Wo. & H. K. Kim: Reductio. Of renal fibrosis as a result of liposome encapsulated clodronate induced macrophage depletion after unilateral ureteral obstruction in rats. Nephron Exp Nephrol, 105, e1-9 (2007) (Pubitemid 46006571)
135. Kitagawa, K., T. Wada, K. Furuichi, H. Hashimoto, Y. Ishiwata, M. Asano, M. Takeya, W. A. Kuziel, K. Matsushima, N. Mukaida & H. Yokoyama: Blockad. Of CCR2 ameliorates progressive fibrosis in kidney. Am J Pathol, 165, 237-237 (2004)
136. Stambe, C., R. C. Atkins, G. H. Tesch, T. Masaki, G. F. Schreine. & D. J. Nikolic-Paterson: Th. Role of p38alpha mitogen-activated protein kinase activation in renal fibrosis. J Am Soc Nephrol, 15, 370-370 (2004)
137. Ma, F. Y., G. H. Tesch, R. A. Flavell, R. J. Davi. & D. J. Nikolic-Paterson: MKK3-p3. Signaling promotes apoptosis and the early inflammatory response in the obstructed mouse kidney. Am J Physiol Renal Physiol, 293, F1556-1563 (2007) (Pubitemid 350085991)
138. Kang, S. W., S. G. Adler, J. Lapag. & R. Natarajan: p3. MAPK and MAPK kinase 3/6 mRNA and activities are increased in early diabetic glomeruli. Kidney Int, 60, 543-543 (2001)
139. Moriwaki, Y., T. Inokuchi, A. Yamamoto, T. Ka, Z. Tsutsumi, S. Takahashi & T. Yamamoto: Effec. Of TNF-alpha inhibition on urinary albumin excretion in experimental diabetic rats. Acta Diabetol, 44, 215-215 (2007)
140. Wada, T., H. Azuma, K. Furuichi, N. Sakai, K. Kitagawa, Y. Iwata, K. Matsushima, S. Takahara, H. Yokoyama & S. Kaneko: Reductio. In chronic allograft nephropathy by inhibition of p38 mitogen-activated protein kinase. Am J Nephrol, 26, 319-319 (2006)
141. Aoudjit, L., M. Stanciu, H. Li, S. Lema. & T. Takano: p3. Mitogen-activated protein kinase protects glomerular epithelial cells from complement-mediated cell injury. Am J Physiol Renal Physiol, 285, F765-774 (2003) (Pubitemid 37140260)
142. Park, S. J. & K. S. Jeong: Cell-type-specifi. Activation of mitogen-activated protein kinases in PAN-induced progressive renal disease in rats. Biochem Biophys Res Commun, 323, 1-1 (2004)
143. Costa, J. C., R. S. Costa, C. G. Silv. & T. M. Coimbra: Enalapri. Reduces the expression of nuclear factor-kappaB and c-Jun. N-terminal kinase in the renal cortices of five-sixths-nephrectomized rats. Am J Nephrol, 26, 281-281 (2006)
144. Flanc, R. S., F. Y. Ma, G. H. Tesch, Y. Han, R. C. Atkins, B. L. Bennett, G. C. Friedman, J. H. Fan & D. J. Nikolic-Paterson: A pathogeni. Role for JNK signaling in experimental anti-GBM glomerulonephritis. Kidney Int, 72, 698-698 (2007)
145. Pillebout, E., J. B. Weitzman, M. Burtin, C. Martino, P. Federici, M. Yaniv, G. Friedlander & F. Terzi: Jun. Protects against chronic kidney disease by regulating paracrine mitogens. J Clin Invest, 112, 843-843 (2003)
146. Bokemeyer, D., D. Panek, H. J. Kramer, M. Lindemann, M. Kitahara, P. Boor, D. Kerjaschki, J. M. Trzaskos, J. Floege & T. Ostendorf: I. Vivo identification of the mitogen-activated protein kinase cascade as a central pathogenic pathway in experimental mesangioproliferative glomerulonephritis. J Am Soc Nephrol, 13, 1473-1473 (2002)
147. Pat, B., T. Yang, C. Kong, D. Watters, D. W. Johnso. & G. Gobe: Activatio. Of ERK in renal fibrosis after unilateral ureteral obstruction: modulation by antioxidants. Kidney Int, 67, 931-931 (2005)
148. Han Y, Masaki T, Hurst LA, Ikezumi Y, Trzaskos JM, Atkins RC, Nikolic-Paterson DJ. ERK-dependent interstitial macrophage proliferation in the obstructed mouse kidney. Nephrology (Epub March 5, 2008).
149. Sakai, N., T. Wada, K. Furuichi, Y. Iwata, K. Yoshimoto, K. Kitagawa, S. Kokubo, M. Kobayashi, S. Takeda, H. Kida, K. Kobayashi, N. Mukaida, K. Matsushima & H. Yokoyama: p3. MAPK phosphorylation and NF-kappa B activation in human crescentic glomerulonephritis. Nephrol Dial Transplant, 17, 998-998 (2002)
150. Sakai, N., T. Wada, K. Furuichi, Y. Iwata, K. Yoshimoto, K. Kitagawa, S. Kokubo, M. Kobayashi, A. Hara, J. Yamahana, T. Okumura, K. Takasawa, S. Takeda, M. Yoshimura, H. Kida & H. Yokoyama: Involvemen. Of extracellular signal-regulated kinase and p38 in human diabetic nephropathy. Am J Kidney Dis, 45, 54-54 (2005)
151. Grimm, D. & M. A. Kay: Therapeuti. Application of RNAi: is mRNA targeting finally ready for prime time? J Clin Invest, 117, 3633-3633 (2007)
152. Scapin, G., S. B. Patel, J. Lisnock, J. W. Becke. & P. V. LoGrasso: Th. Structure of JNK3 in complex with small molecule inhibitors: structural basis for potency and selectivity. Chem Biol, 10, 705-705 (2003)
153. Omori, S., M. Hida, H. Fujita, H. Takahashi, S. Tanimura, M. Kohn. & M. Awazu: Extracellula. Signalregulated kinase inhibition slows disease progression in mice with polycystic kidney disease. J Am Soc Nephrol, 17, 1604-1604 (2006)
154. Dambach, D. M.: Potentia. Adverse effects associated with inhibition of p38alpha/beta MAP kinases. CurrTopics Med Chem, 5, 929-929 (2005)
155. Wang, L. H., C. G. Besirl. & E. M. Johnson, Jr.: Mixed-lineag. Kinases: a target for the prevention of neurodegeneration. Ann Rev Pharmacol Toxicol, 44, 451-451 (2004)
156. Parkinson Study Group: Mixe. Lineage kinase inhibitor CEP-1347 fails to delay disability in early Parkinson disease. Neurology, 69, 1480-1480 (2007)
157. Uehara, T., X. Xi Peng, B. Bennett, Y. Satoh, G. Friedman, R. Currin, D. A. Brenner & J. Lemasters: c-Ju. N-terminal kinase mediates hepatic injury after rat liver transplantation. Transplantation, 78, 324-324 (2004)